Literature DB >> 12175270

Behavioral treatment of migraine in children and adolescents.

Robert J Baumann1.   

Abstract

Behavioral interventions, particularly biofeedback and relaxation therapy, have demonstrated their effectiveness in the treatment of both adults and older children with migraine in controlled trials. The physiological basis for their effectiveness is unclear, but data from one trial suggest that levels of plasma beta-endorphin can be altered by relaxation and biofeedback therapies. The data supporting the effectiveness of behavioral therapies are less clear-cut in children than in adults, but that is also true for the data supporting medical treatment. This is due in part to methodological issues, especially the lack of a specific test for migraine, which has hampered research and helped lead to an inappropriate de-emphasis on care for childhood headache. In addition, migraine headaches in children are often briefer and have a higher rate of spontaneous remission than those experienced by adults, making it difficult to separate effective from ineffective treatments. While it is widely believed that stress is a major factor in childhood migraine, well-designed studies have had difficulty developing data to support this viewpoint. Many clinicians utilize 'confident reassurance', reassuring the family that the child is not seriously ill, in the belief that having migraine headaches can be stressful. They also modify behaviors that are believed to trigger migraine headaches, such as poor sleep habits or irregular meal times. Relaxation therapies use techniques such as progressive relaxation, self-hypnosis, and guided imagery. Several studies have found relaxation therapies to be as effective, or more effective, in reducing the frequency of migraine headaches than modest doses of a beta-blockade medication, although one study found relaxation therapy to be no more effective than a control program. Several studies have demonstrated that these therapies can be taught to children in a low cost but effective manner. Biofeedback therapies commonly use an apparatus to demonstrate a physiological effect. Most commonly in pediatrics, children are taught to raise the temperature of one of their fingers. This can be done with or without a thermometer. Several groups have shown that these techniques can be taught to children and that their use is associated with fewer and briefer migraine headaches. People who experience migraines can also experience episodic headaches throughout life. An important consideration is preparing children to deal with future headaches, allowing them to feel in control of their health. Behavioral therapies have the potential to do this, giving the child access to a technique that can be easily resumed without a medical visit or prescription.

Entities:  

Mesh:

Year:  2002        PMID: 12175270     DOI: 10.2165/00128072-200204090-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  50 in total

Review 1.  Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia.

Authors: 
Journal:  JAMA       Date:  1996 Jul 24-31       Impact factor: 56.272

2.  Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses.

Authors:  J D Carroll; M Reidy; P A Savundra; N Cleave; J McAinsh
Journal:  Cephalalgia       Date:  1990-04       Impact factor: 6.292

Review 3.  A critical note on psychophysiological stress research into migraine patients.

Authors:  J Passchier
Journal:  Cephalalgia       Date:  1994-06       Impact factor: 6.292

4.  A computerized behavioral assessment for children with headaches.

Authors:  A Leviton; W V Slack; B Masek; D Bana; J R Graham
Journal:  Headache       Date:  1984-07       Impact factor: 5.887

5.  Treatment of childhood migraine using autogenic feedback training.

Authors:  E L Labbé; D A Williamson
Journal:  J Consult Clin Psychol       Date:  1984-12

6.  Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria. Pediatric Headache Committee of the American Association for the Study of Headache.

Authors:  P Winner; W Wasiewski; J Gladstein; S Linder
Journal:  Headache       Date:  1997-10       Impact factor: 5.887

7.  Effects of behaviour therapy on migraine and plasma beta-endorphin in young migraine patients.

Authors:  H vd Helm-Hylkema; J F Orlebeke; L A Enting; J H Thijssen; J van Ree
Journal:  Psychoneuroendocrinology       Date:  1990       Impact factor: 4.905

8.  Increasing prevalence of headache in 7-year-old schoolchildren.

Authors:  M Sillanpää; P Anttila
Journal:  Headache       Date:  1996-09       Impact factor: 5.887

9.  Age-related headache characteristics.

Authors:  A Leviton; W V Slack; D Bana; J R Graham
Journal:  Arch Neurol       Date:  1984-07

10.  Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study.

Authors:  A Pradalier; G Serratrice; M Collard; E Hirsch; J Feve; M Masson; C Masson; J Dry; G Koulikovsky; G Nguyen
Journal:  Cephalalgia       Date:  1989-12       Impact factor: 6.292

View more
  5 in total

1.  Prophylaxis of migraine in children.

Authors:  Satinder Aneja
Journal:  Indian J Pediatr       Date:  2013-10-17       Impact factor: 1.967

Review 2.  Migraine in children and adolescents: a guide to drug treatment.

Authors:  Mirja L Hämäläinen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Migraine management: How do the adult and paediatric migraines differ?

Authors:  M Sonal Sekhar; Shalini Sasidharan; Siby Joseph; Anand Kumar
Journal:  Saudi Pharm J       Date:  2011-07-20       Impact factor: 4.330

4.  Benign paroxysmal vertigo of childhood: A review of the literature.

Authors:  Glenna Batson
Journal:  Paediatr Child Health       Date:  2004-01       Impact factor: 2.253

Review 5.  Overview of diagnosis and management of paediatric headache. Part II: therapeutic management.

Authors:  Cristiano Termine; Aynur Ozge; Fabio Antonaci; Sophia Natriashvili; Vincenzo Guidetti; Ciçek Wöber-Bingöl
Journal:  J Headache Pain       Date:  2010-12-18       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.